Cicatrix, Hypertrophic
15
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
1 terminated out of 15 trials
90.9%
+4.4% vs benchmark
7%
1 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Treatment of Hypopigmented Scars With Bimatoprost
Fractional CO2 Laser Treatment of Hypertrophic Scars
Pilot Study of a Novel 532nm KTP Laser for the Treatment of Fresh Surgical Scars
The Clinical Efficacy And Safety Of SkinStylus Microneedling System
Laser Therapy for Pediatric Burn Scars
The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Post Burn Scars
A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects
A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars
Effectiveness of a Combined Pressure and Silicone Intervention for Hypertrophic Scar Treatment
The Development and Application of "Scar-care" Padding on Management of Hypertrophic Scar
FS2 Safety and Tolerability Study in Healthy Volunteers
Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars
Prospective Clinical Trials on Skin Wound Healing in Young and Aged Individuals
To Study Gene Expression of Postburn Hypertrophic Scar
Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage